Novavax | NVAX - SCHULD





SCHULD Veränderung Datum
Adma Biologics USD 204.41M 121.28M 2026-03
Agenus USD 35.54M 2.34M 2025-03
AstraZeneca USD 32.24B 1.68B 2026-06
BioCryst Pharmaceuticals USD 828.6M 510K 2024-12
Cassava Sciences USD 0 0 2024-12
Geron USD 122.07M 74K 2026-03
GlaxoSmithKline GBP 19.06B 1.34B 2026-03
MannKind USD 330.96M 36.48M 2026-03
Merck USD 49.12B 222M 2026-03
Minerva Neurosciences USD 0 0 2024-09
Moderna USD 1.3B 7M 2026-03
Novartis USD 47B 14.98B 2026-03
Novavax USD 233.31M 4.23M 2024-09
Pfizer USD 63.19B 536M 2026-06
Sanofi EUR 23.58B 3.56B 2026-06
Sarepta Therapeutics USD 1.04B 3.08M 2026-03
TG Therapeutics USD 754.44M 884K 2026-06